Treatment with verapamil and trandolapril in patients with congestive heart failure and angina pectoris or myocardial infarction

American Heart Journal

Volumn 134, Issue 2 II, 1997, Pages

  Hansen, J F ^a   Hagerup, L ^a   Sigurd, B ^a   Pedersen, F ^a   Mellemgaard, K ^a   Bjergaard, O P ^a  

^a BISPEBJERG HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CALCIUM ANTAGONIST; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; GLYCERYL TRINITRATE; NITRIC ACID DERIVATIVE; TRANDOLAPRIL; VERAPAMIL;

ANGINA PECTORIS; ARTICLE; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEATH; DOUBLE BLIND PROCEDURE; EXERCISE; HEART INFARCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART REINFARCTION; HUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; UNSTABLE ANGINA PECTORIS;

EID: 0030968581     PISSN: 00028703     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-8703(97)70008-5     Document Type: Article

References (31)

1. Danish Study Group on Verapamil in Myocardial Infarction The effect of verapamil on mortality and major events after myocardial infarction: the Danish Verapamil Infarction Trial (DAVIT) II Am J Cardiol 66 1990 779 785
2. M Packer Calcium channel blockers in chronic heart failure: the risk of “physiologically” rational therapy Circulation 82 1990 2254 2257
3. Danish Study Group on Verapamil in Myocardial Infarction Secondary prevention with verapamil after myocardial infarction Am J Cardiol 66 1990 33I 40I
4. The Acute Infarction Ramipril Efficacy AIRE Study Investigators Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure Lancet 342 1993 821 828
5. JF Hansen ACE inhibitors and calcium antagonists in the treatment of congestive heart failure Cardiovasc Drug Ther 9 1995 503 507
6. JF Hansen L Tingsted V Rasmussen JK Madsen CM Jespersen Verapamil and angiotensin-converting enzyme inhibitors in patients with coronary artery disease and reduced left ventricular ejection fraction Am J Cardiol 77 1996 16D 21D
7. JF Hansen L Hagerup B Sigurd F Pedersen K Mellemgaard O Pedersen-Bjergaard LS Mortensen DAVIT Study Group Cardiac event rates after acute myocardial infarction in patients treated with verapamil and trandolapril versus trandolapril alone Am J Cardiol 79 1997 738 741
8. L Kørber C Torp-Pedersen J Carlsen H Bagger P Eliasen K Lyngborg the TRACE Study Investigators A clinical trial of angiotensin converting enzyme inhibitor trandolapril in patients with left ventricular dysfunction after an acute myocardial infarction N Engl J Med 333 1995 1670 1676
9. U Elkayam J Amin A Mehra J Vasques L Weber SH Rahimtoola A prospective, randomized, double-blind, crossover study to compare the efficacy and safety of chronic nifedipine therapy with that of isosorbid dinitrate and their combination in the treatment of chronic congestive heart failure Circulation 82 1990 1954 1961
10. WA Littler DJ Sheridan UK Study Group Placebo controlled trial of felodipine in patients with mild to moderate heart failure Br Heart J 73 1995 428 433
11. M Packer CM O’Connor JK Ghali ML Pressler PE Carson RN Belkon the Prospective Randomized Amlodipine Survival Evaluation Study Group Effect of amlodipine on morbidity and mortality in severe chronic heart failure N Engl J Med 335 1996 1107 1114
12. M Packer Pathophysiological mechanisms underlying the adverse effect of calcium channel-blocking drugs in patients with chronic heart failure Circulation 80 Suppl IV 1989 IV-59B IV-67B
13. WG Nayler Calcium antagonists, stunning, hibernation: an overview LH Opie Stunning, hibernation and calcium in myocardial ischemia and reperfusion 1992 Kluwer Academic Publishers Boston (MA) 226 234
14. S Betocchi F Piscione P Perrone-Filardi L Pace M Capelli-Bigazzi B Alfano Effect of intravenous verapamil on left ventricular relaxation and filling in stable angina pectoris Am J Cardiol 66 1990 818 825
15. A Lahiri AE Rodrigues PR Caboni ER Raftery Effect of long term treatment with calcium antagonists on left ventricular diastolic function in stable angina pectoris and heart failure Circulation 81 Suppl III 1990 III-130 III-138
16. JF Serato BL Zaret DS Schulman HR Black R Soufer Usefulness of verapamil on congestive heart failure associated with abnormal left ventricular filling and normal left ventricular systolic performance Am J Cardiol 66 1990 981 986
17. NR Cutler RJ Anders SS Jhee JJ Sramek NA Awan J Bultas Placebo-controlled evaluation of three doses of a controlled-onset, extended-release formulation of verapamil in the treatment of stable angina pectoris Am J Cardiol 75 1995 1102 1106
18. CM Jespersen DAVIT Study Group The effect of verapamil on major events in patients with impaired cardiac function recovering from acute myocardial infarction Eur Heart J 14 1993 540 545
19. M Vaage-Nilsen V Rasmussen NH Hollander JF Hansen DAVIT Study Group Prevalence of transient myocardial ischemia during the first year after a myocardial infarction: effect of treatment with verapamil Eur Heart J 13 1992 666 670
20. NH Wallén C Held N Rehnqvist P Hjemdahl Platelet aggregability in vivo is attenuated bv verapamil but not metoprolol in patients with stable angina pectoris Am J Cardiol 75 1995 1 6
21. MA Pfeffer E Braunwald L Moye L Basta EJ Brown TE Cuddy the SAVE Investigators Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction N Engl J Med 32 1992 669 677
22. E Ambrosioni C Borghi B Magnani SMILE Study Investigators The effect of angiotensin converting enzyme inhibitor zofenopril on mortality and morbidity after anterior myocardial infarction N Engl J Med 332 1995 80 85
23. The SOLVD Investigators Effect of enalapril on survival in patients with reduced left ventricular ejection fraction and congestive heart failure N Engl J Med 325 1991 293 302
24. The SOLVD Investigators Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fraction N Engl J Med 327 1992 685 691
25. JGF Cleland E Henderson J McLenachan IN Findlay HJ Dargie Effect of captopril, an angiotensin converting enzyme inhibitor in patients with angina pectoris and heart failure J Am Coll Cardiol 17 1991 733 739
26. M.St.J Sutton MA Pfeffer T Plappert JL Rouleau LA Moye GR Degenais the SAVE Investigators Quantitative two-dimensional echocardiographic measurements are major predictors of adverse cardiovascular events after acute myocardial infarction: the protective effect of captopril Circulation 89 1994 68 75
27. B Greenberg MA Quinones C Koilpillar M Limacher D Shindler C Benedict the SOLVD Investigators Effect of long-term enalapril therapy on cardiac structure and function in patients with left ventricular dysfunction: results of the SOLVD echocardiographic study Circulation 91 1995 2573 2581
28. JB Young Reduction of ischemic events with angiotensin converting enzyme inhibitors: lessons and controversy emerging from recent clinical trials Cardiovasc Drug Ther 9 1995 89 102
29. HSJ Lindsay AG Zaman JC Cowan ACE inhibitors after myocardial infarction: patient selection or treatment for all Br Heart J 73 1995 397 400
30. R Kornowski U Goldbourt M Zion L Mandelzweig E Kaplinsky Y Levo the SPRINT Study Group Predictors and long term prognostic significance of recurrent infarction in the year after a first myocardial infarction Am J Cardiol 72 1993 883 888
31. SG Ball S Hall GD Murray ACE inhibition, atherosclerosis and myocardial infarction: the AIRE study in practice Eur Heart J 15 Suppl B 1993 20 25